Some of the key facts of the Clostridium Difficile Infections Market Report: ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Recurring Clostridioides difficile infections could be costing hospitals millions, an AtlantiCare Regional Medical Center study found. The study, published Sept. 29 in Cambridge Core, included 29 ...

A new antibiotic to fight the deadly "superbug" C. diff has proved effective in clinical trials. Treating patients with ibezapolstat provided high rates of "sustained" clinical cures, say American ...

The company said durable protection from a single dose is highly valuable, especially where vaccine access is limited.

SYRACUSE, N.Y. — As the third week of September unfolds, doctors are alerting asthma sufferers to brace for what is known as "Asthma Peak Week," a period marked by worsening symptoms and increased ...

Multiple myeloma is a form of blood cancer you may never have heard of–and that makes sense, because it’s, thankfully, pretty rare. That said, if you’re one of the unlucky few (your average lifetime ...

As summer comes to an end, COVID-19 cases are on the rise again in California. While respiratory viruses usually peak in the winter, the novel coronavirus can also surge in the warmer months.